Pembrolizumab
Commons · Question 88815 · Tabled 10 Nov 2025 · Department of Health and Social Care · Official record
Answered 26 Nov 2025
Question
Asked by Lee Anderson
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of making pembrolizumab available on the NHS for longer than two years.
Answer
Answered by Zubir Ahmed, 26 Nov 2025
The National Institute for Health and Care Excellence (NICE) is the independent body that develops authoritative, evidence-based recommendations on whether new licensed medicines should be routinely funded by the National Health Service based on an assess...